PharmaBoardroom

Interview with Lorenzo Mastromonaco, Vice President, Novo Nordisk…

Novo Nordisk is one of the very few pharmaceutical multinationals that has such a strong focus on one therapeutic area. Although the company is now…

Interview with Dirceu Barbano, Director, ANVISA

10 days ago, your Swedish counterpart Mats Larsson made a technical visit here at ANVISA and said he had a lot to learn. What is it about ANVISA that…

Interview with Carlito Realuyo, President and General Manager,…

Mr. Realuyo, you have been in sanofi-aventis for 16 years, three of which were at the head. What have been the major achievements that the company has…

Interview with Bernard J. Mauritz, Executive Director, NEPROFARM

In order to understand the culture behind the business that this association represents, what would you say is the perception of OTC and…

Interview with Michael Klein, Clinicial Operations SE Asia,…

What role does Indonesia play within Quintiles' Asian operations? Quintiles has been growing dramatically across the South East Asian Region, which…

Interview with Emiliano Gummati, General Manager, Cegedim…

Ten years of experience in the Dendrite group enabled you to cover a number of international positions, before its acquisition by Cegedim in May 2007.…

Interview with Louis Hodossy, General Manager, Roche Hungary

Hungary has been recognized as one of the largest pharmaceutical and healthcare markets in Central and Eastern Europe, and can obviously not be…

Interview with Hagop Barsoumian, President, Chiesi Brazil

Yesterday, Minister Pimentel unveiled the Brazil Maior plan to increase competitiveness and growth across a variety of industrial sectors. If you had…

Interview with Manuel Fernando Loaiza Sotomayor, President, Bagó…

Sao Paulo state is responsible for some 85% of pharmaceutical production, and last week Minister Pimentel was in the city of Sao Paulo elaborating on…